Stock Screener App

Frei -

Installieren

3.51

3.04% -0.11

Salarius Pharmaceuticals Inc (SLRX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	43.82% 0.9656	1.7187	1.4887	1.0065	1.4675
Operating Income/Loss	43.82% -0.9656	-1.7187	-1.4887	-1.0065	-1.4675
Income/Loss From Continuing Operations Before Tax	43.97% -0.9578	-1.7095	-1.4639	-0.9721	-1.4244
Income/Loss From Continuing Operations After Tax	43.97% -0.9578	-1.7095	-1.4639	-0.9721	-1.4244
Net Income/Loss	43.97% -0.9578	-1.7095	-1.4639	-0.9721	-1.4244
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	27.58% 2.1229	1.6639	0.1608	1.2819	0.6004
Diluted Average Shares	27.58% 2.1229	1.6639	0.1608	1.2819	0.6004
Basic Earnings Per Share	56.31% -0.45	-1.03	-0.66	-0.76	-2.37
Diluted Earnings Per Share	56.31% -0.45	-1.03	-0.66	-0.76	-2.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.41

0.51%

GMAB

$28.83

0.42%

INCY

$101.65

0.17%

BNTX

$103.85

0.08%

ONC

$310.01

0.52%

INSM

$184.61

0.50%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters